BioCentury | Aug 22, 2016
Company News

Trovagene sales and marketing update

...deletions and exon 20 T790M and exon 21 L858R mutations in urinary cell-free DNA (cfDNA); Trovera BRAF...
BioCentury | Apr 28, 2014
Clinical News

BRAF V600E oncogene mutation assay: Clinical trial data

...had previously tested positive for BRAF V600E mutations by a CLIA-certified laboratory showed that Trovagene's BRAF V600E oncogene mutation assay...
...assay to detect and longitudinally monitor BRAF mutations. Trovagene Inc. (NASDAQ:TROV), San Diego, Calif. Product: BRAF V600E oncogene mutation assay...
Items per page:
1 - 2 of 2